so if they're making topical generic products that are not protected by any patents, can someone help me understand, what is Acrux's competitive advantage in this? What makes their product pipeline any more likely to be commercially successful than any other topical generic that may come from the large global generic players? What am i missing?
- Forums
- ASX - By Stock
- ACR
- Ann: Acrux Presents At Bioshares Biotech Summit
ACR
acrux limited
Add to My Watchlist
10.0%
!
1.8¢

Ann: Acrux Presents At Bioshares Biotech Summit, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.8¢ |
Change
-0.002(10.0%) |
Mkt cap ! $7.366M |
Open | High | Low | Value | Volume |
1.8¢ | 1.8¢ | 1.8¢ | $8.471K | 470.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 370600 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 691823 | 0.017 |
10 | 960173 | 0.016 |
5 | 1311882 | 0.015 |
2 | 140000 | 0.014 |
3 | 486850 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 370600 | 1 |
0.021 | 111922 | 1 |
0.022 | 100000 | 1 |
0.023 | 381179 | 1 |
0.024 | 201073 | 3 |
Last trade - 13.32pm 25/07/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online